Literature DB >> 11826941

Use of postmenopausal estrogen replacement therapy from 1981 to 1997.

Ilona Csizmadi, Andrea Benedetti, Jean-François Boivin, James A Hanley, Jean-Paul Collet.   

Abstract

Mesh：

Year:  2002        PMID： 11826941      PMCID： PMC99271     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Postmenopausal hormone-replacement therapy--time for a reappraisal?

Authors:  L A Brinton; C Schairer
Journal:  N Engl J Med       Date:  1997-06-19       Impact factor: 91.245

2.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors:  D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

3.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

Authors:  K M Brett; J H Madans
Journal:  Am J Epidemiol       Date:  1997-03-15       Impact factor: 4.897

4.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

5.  Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage.

Authors:  C R Sharpe; J P Collet; M McNutt; E Belzile; J F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640
  5 in total
  1 in total

1.  Jiawei Yanghe Decoction Regulates Bone-Lipid Balance through the BMP-SMAD Signaling Pathway to Promote Osteogenic Differentiation of Bone Mesenchymal Stem Cells.

Authors:  Yunfeng Luo; Hanting Xia; Jiacai Wang; Qian Hu; Yinghua Luo; Jiangyuan Liu; Zhijun Yang; Wei Li; Hongyu Wang; Fuwei Li; Zhaochong Mao; Wenlong Yang; Fengyun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-20       Impact factor: 2.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.